A-shares are ruthless, and Hong Kong stocks are even more brutal—Shandong Molong, Foxconn Interconnect Technology, and Fibocom are taking turns to plunge, leaving people emotionally numb. Although BeiGene is rock solid today, honestly, who dares to heavily invest in the pharmaceutical sector these days? JD Health recently entered the Tech 100, only to face consecutive drops. This market is truly exhausting—chasing feels risky, and cutting losses makes you wonder if a rebound is coming. It’s all about faith now, staying tough by ignoring the charts and sticking to your convictions…
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
